Business & Finance
Vaxart Doses First Patient in Randomised Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
18 April 2019 - - US-based biotechnology company Vaxart, Inc has started dosing subjects in the randomised cohort of the Phase 1b bivalent norovirus vaccine clinical trial, the company said.
WellDyneRx names new chairman and chief executive officer
16 April 2019 - WellDyneRx, an independent Pharmacy Benefit Manager involved in delivering solutions through integrated data and technology, has named Jeff Park as its new chairman and chief executive...
EMMAC Life Sciences closes acquisition of UK based Rokshaw
9 April 2019 - Medical cannabis company EMMAC Life Sciences Ltd said on Tuesday that its EMMAC UK Limited UK subsidiary has completed the acquisition of the entire issued share capital of Rokshaw Limi...
Qiagen, LabCorp Launch Collaboration to Provide Day-One Access for Patients to Innovative Companion Diagnostics at the Time of Drug Approvals
8 April 2019 - - Dutch diagnostics developer Qiagen N.V. (NYSE: QGEN) has inked a master service agreement with US-based LabCorp (NYSE: LH) to further accelerate the access of cancer patient...
Agilent Launches New System for RNA and DNA Quality Control Laboratories
5 April 2019 - - US-based life sciences, diagnostics and applied chemical company Agilent Technologies Inc. (NYSE: A) is shipping of a new instrument that offers laboratories a more affordable, l...
Bio-Rad Laboratories Names Daskal as EVP and Chief Financial Officer
5 April 2019 - - US-based life science research and clinical diagnostic products company Bio-Rad Laboratories, Inc. (NYSE: BIO) has appointed Ilan Daskal as executive vice president and chief financia...